Sensitivity, specificity, accuracy percentage and error percentage of prostatic specific antigen [PSA] in diagnosis of cancer prostate
El-Minia Medical Bulletin. 1993; 4 (1): 53-61
in English
| IMEMR
| ID: emr-28006
ABSTRACT
Prostatic specific antigen [PSA] was estimated in 20 normal males [control group] and 22 patients with cancer prostate [cases]. Detection of antigen by immunoassay method and diagnosis was confirmed by histopathology. Sensitivity, specificity, accuracy percentage and error percentage of PSA in the diagnosis of cancer prostate in patients with metastasis were 95.2%, 100%, 95.5% and 4.5%, respectively, and in patients without metastasis were 85.7%, 100%, 86.4% and 13.6%, respectively. PSA detection was recommended for early detection and screening of any suspected prostatic swelling
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Prostate
/
Prostatic Neoplasms
/
Sensitivity and Specificity
/
Diagnostic Errors
Type of study:
Screening study
Limits:
Humans
/
Male
Language:
English
Journal:
El-Minia Med. Bull.
Year:
1993
Similar
MEDLINE
...
LILACS
LIS